Catalent's Open Letter to Customers Regarding Novo Holdings
Oct 21, 2024 · Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings. Committed to Continuing to Serve Customers and Patients as a Leading Global, Independent, Full-Service CDMO Post-Close. Alessandro Maselli to Remain President and CEO of Catalent Post-Close.
Novo Holdings to Acquire Catalent
Feb 5, 2024 · Catalent and Novo Holdings have entered into a merger agreement in an all-cash transaction that values Catalent at $16.5 billion. Catalent Stockholders to Receive $63.50 Per Share in Cash, Representing a 47.5% Premium to the 60-day Volume-Weighted Average Price as of February 2, 2024
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
6 days ago · The $16.5 billion deal, announced in February, underscores Novo Nordisk's drive to boost output of Wegovy, a once-weekly injection. After the deal closes, Novo Holdings will sell three of Catalent ...
EU regulators see info from rivals, customers in Catalent's sale
In February, Catalent agreed to be acquired by Novo Holdings for $63.50 a share. Novo Holdings will then sell three Catalent manufacturing sites to Novo Nordisk , which should help increase ...
Catalent Issues Open Letter to Customers Regarding Pending …
Oct 21, 2024 · Following the closing of our transaction, as a private company under Novo Holdings’ ownership, Catalent will continue to operate as a leading global, independent, full-service CDMO.
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 …
Nov 8, 2024 · Novo and Lilly/Taylor Tieden for BioSpace. With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention. Novo Holdings’ $16.5 billion acquisition of CDMO giant Catalent continues to be under antitrust ...
Catalent Misses Q1 Revenue Estimates Ahead of $16.5 Billion ... - U.S. News
Nov 5, 2024 · Catalent's revenue for fiscal first quarter ended Sept. 30 was $1.02 billion, marginally below analysts' estimates of $1.06 billion, according data compiled by LSEG. Revenue from its biologics ...
Warren challenges Novo Holdings' proposed Catalent buyout
Oct 10, 2024 · As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny.
Consumer Groups Ask FTC to Block Novo Holdings-Catalent Deal - U.S. News
Oct 17, 2024 · NEW YORK (Reuters) -U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, the controlling shareholder of Novo Nordisk,...
Catalent CEO to Remain in Charge of Contract Drugmaker After Novo …
Oct 21, 2024 · (Reuters) - Catalent CEO Alessandro Maselli said on Monday he will remain at the helm of the U.S.-based contract drugmaker after it is acquired by Novo Holdings, the controlling shareholder...